in

PROTECTIVE INSURANCE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Protective Insurance Corporation – PTVCA, PTVCB

NEW ORLEANS, March 29, 2021 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Protective Insurance Corporation (NasdaqGS: PTVCA, PTVCB) to The Progressive Corporation (NYSE: PGR). Under the terms of the proposed transaction, shareholders of Protective will receive only $23.30 in cash for each share of Protective that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.


KSF Filing Alert (PRNewsfoto/Kahn Swick & Foti, LLC)

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([email protected]) toll free at any time at 855-768-1857, or visit  https://www.ksfcounsel.com/cases/nasdaqgs-ptvca/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC
1100 Poydras St., Suite 3200
New Orleans, LA 70163

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/protective-insurance-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick–foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-protective-insurance-corporation–ptvca-ptvcb-301257869.html

SOURCE Kahn Swick & Foti, LLC

Written by Tenner Smith

Tenner Smith - I have experience in financial intelligence and automated intelligence. In industry I have worked on artificial intelligence and machine learning. Tenner Smith is a reporter at DF media.

Digital Security by Design Business-led Demonstrators

Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates